Laboratory Tests for Nephrotic Syndrome Evaluation
To evaluate for nephrotic syndrome, you need to measure urinary protein-to-creatinine ratio (uPCR) or albumin-to-creatinine ratio (ACR) on a spot urine sample, serum albumin, and serum creatinine to assess kidney function. 1
Essential Initial Laboratory Tests
Urine Studies
Proteinuria quantification is the cornerstone of diagnosis:
- Spot urine protein-to-creatinine ratio (uPCR): Nephrotic-range proteinuria is defined as uPCR ≥200 mg/mmol (2 g/g or 2000 mg/g) 1
- Alternatively, spot urine albumin-to-creatinine ratio (ACR) ≥2200 mg/g (≥220 mg/mmol) indicates nephrotic-range proteinuria 2
- Urine dipstick can be used for initial screening (3+ or 4+ suggests nephrotic-range proteinuria), but must be confirmed with quantitative measurement 1
Important note: First morning urine samples are preferred for initial testing to minimize variability from exercise, posture, and diurnal variation 3. If dipstick is positive (≥1+), proceed immediately to quantitative uPCR or ACR measurement 3.
Blood Tests
Core laboratory measurements:
- Serum albumin: Hypoalbuminemia is defined as <30 g/L (3 g/dL) 1
- Be aware that different assays (bromocresol green vs. bromocresol purple) give different values—a critical distinction when assessing thromboembolism risk 4
- Serum creatinine: To calculate estimated glomerular filtration rate (eGFR) and assess kidney function 5
- Lipid panel: Hyperlipidemia is commonly present though not required for diagnosis 6, 7
Additional Blood Work
Complete blood count (CBC) and comprehensive metabolic panel should be obtained to assess for complications and secondary causes 8.
Urinalysis and Sediment Examination
Routine urinalysis with microscopic examination is essential 5:
- Assess for hematuria (red cell casts, acanthocytes suggest glomerulonephritis)
- Evaluate for infection or other urinary abnormalities
Secondary Cause Evaluation
In adults, additional serologic testing should be guided by clinical suspicion rather than obtained routinely 8. However, consider:
- Anti-phospholipase A2 receptor (PLA2R) antibodies: If positive, diagnostic of membranous nephropathy without need for biopsy 7
- Hepatitis B and C serologies: If risk factors present 9
- HIV testing: Particularly in high-risk populations 9
- Serum and urine protein electrophoresis: If age >50 or clinical suspicion for myeloma/amyloidosis 8
- Antinuclear antibodies (ANA), complement levels (C3, C4): Only if clinical features suggest lupus 8
- Hemoglobin A1c or fasting glucose: To screen for diabetes 6
In children aged 1-18 years, extensive serologic workup is typically not needed at initial presentation, as most cases are minimal change disease 1, 4, 1. Proceed directly to empiric corticosteroid therapy without biopsy in this age group.
Practical Algorithm
Obtain spot urine sample (preferably first morning void)
- Measure uPCR or ACR quantitatively
- If uPCR ≥2000 mg/g (200 mg/mmol) → nephrotic-range proteinuria confirmed
Draw blood for:
- Serum albumin (if <30 g/L with nephrotic-range proteinuria → nephrotic syndrome diagnosed)
- Serum creatinine (calculate eGFR)
- Lipid panel
- CBC and comprehensive metabolic panel
Perform urinalysis with microscopy to evaluate sediment
Add targeted serologies only if:
- Adult patient (consider PLA2R antibodies, age-appropriate screening)
- Clinical features suggest secondary cause (diabetes, infection, autoimmune disease)
Critical Pitfalls to Avoid
- Do not rely on dipstick alone—always confirm with quantitative uPCR or ACR 3
- Do not order 24-hour urine collections routinely—spot urine ratios are equally accurate and more practical 9, 3
- Do not obtain extensive serologic panels reflexively in adults—they rarely change management without clinical suspicion 8
- Be aware of factors causing false results: menstruation, urinary tract infection, and vigorous exercise can falsely elevate proteinuria 3
- Account for assay differences in albumin measurement when assessing thromboembolism risk 4